Microdosing Effects: An Honest Overview

"Microdosing effects" is a phrase you'll see everywhere, often followed by big promises. We're taking a different route: what people report, what research has actually looked at, and where the limits of current knowledge lie.

The short answer: the effects of microdosing that people report are mostly subtle and subjective. Some describe feeling more present or engaged, others notice nothing, and some report unpleasant effects such as restlessness or poor sleep. Placebo-controlled studies have so far found that much of what people report also appears with a placebo.

First, a definition

Microdosing means taking a very small amount of a psychedelic substance, such as psilocybin, at a level meant to stay below the threshold of noticeable perceptual effects. The aim is not an altered state of consciousness, but a practice that fits into an ordinary day. We compare the two in full dose vs microdose: what's the difference.

What people report

Most of what we "know" about microdosing comes from personal accounts, surveys and online communities. These accounts are interesting, but they describe subjective experiences, not guaranteed effects.

Thinking and creativity

Some people describe feeling more open to new ideas, more inclined to look at a problem from a different angle, or more engaged in their work. Others notice no difference at all.

Mood and emotions

Some people say they feel a little more present, more connected to others or to themselves, or more attentive to their emotions. Here too, accounts vary enormously, and they don't allow any conclusion about an effect on health.

The body

At microdose level, physical sensations are generally described as subtle or absent. Some people mention a slight change in energy, appetite or sensory perception; others feel nothing. More on this in what a microdose can feel like.

Less pleasant experiences

Honesty means mentioning these too. Some people report restlessness, nervousness, trouble sleeping, headaches, an upset stomach or tiredness the next day. If that happens to you, stop and talk to a doctor. See also microdosing side effects and who should not microdose.

What research has actually shown

Research on microdosing is recent, and the data remain preliminary. We look at it in more detail in what research says about microdosing, and its limits.

• Early studies were mostly observational: questionnaires filled in by people who were already microdosing. Useful for generating hypotheses, but prone to bias. People with a positive experience are more likely to respond, and they know what they took.
• Placebo-controlled studies published in 2021 and 2022, including a self-blinding study by Szigeti et al. (2021), found that the improvements participants reported were often similar in the microdose and placebo groups. Expectations seem to account for a large part of what people perceive.
• Results are mixed. Some controlled studies observe small differences on certain measures, others observe none. None of this supports firm conclusions about effects in everyday life.

How to read a study on microdosing effects

Not all studies carry the same weight. The main types you'll come across:

Type of evidence	What it can tell us	Main limits
Personal accounts and forums	Which experiences people describe	No comparison, strong selection bias
Online surveys	Patterns across many users	Self-reported; participants know what they took
Laboratory and animal studies	Possible mechanisms	Often higher doses, far from everyday life
Placebo-controlled trials	Whether an effect exceeds placebo	Still few, small and short

When you read a headline about microdosing effects, ask a few questions. Was there a placebo group? Did participants know what they had taken? How many people took part, and for how long? Was the effect measured with a questionnaire or an objective test? A small difference on one measure among many can also appear by chance.

Placebo and expectations

Placebo doesn't mean "imaginary". It describes real changes that come from context and expectations rather than from the substance. With microdosing, expectations are often high: people have read enthusiastic stories, choose a special day and watch themselves closely. All of this can shape what they report.

The self-blinding study by Szigeti et al. addressed this by letting participants prepare their own capsules, some with a microdose and some without, so they did not know which they were taking. Blinding is never perfect: when someone notices a sensation, they may guess they took the active dose, and that guess can itself colour the day.

The practical lesson: "I felt something" and "I felt nothing" are both valid observations, and neither proves much on its own. Notes kept on dose days and non-dose days give a fairer picture.

And the mechanisms?

In the body, psilocybin is converted into psilocin, which interacts with serotonin receptors, notably the 5-HT2A receptor. Researchers are exploring what this might mean at very low doses, but the question remains open: whether, and how, such small amounts produce noticeable effects has not been established.

Research continues

Universities and research institutes in several countries are studying psychedelics. It's an active field, and the coming years will probably tell us more about what microdosing does and doesn't do. Until then, it pays to read bold headlines with caution, whether they're enthusiastic or alarmist.

Legal status and responsibility

Psychedelics are regulated very differently from one country to another, and in many countries psilocybin is a controlled substance. Knowing the rules where you live is part of a responsible approach. For the Netherlands and Europe, see the legal status of magic truffles. So is being honest with yourself about your health and your reasons for trying.

Why effects vary from one person to another

Even with the same amount, experiences differ. Among the factors people mention:

• Individual sensitivity: body weight, metabolism and personal history all play a part.
• Context: sleep, stress, caffeine, the kind of day ahead.
• Timing: if anything is noticed, it tends to follow the general timeline of psilocybin; see how long a microdose lasts.
• Frequency: tolerance builds with repeated use, which is why many protocols include rest days. More in can you microdose every day?

Research on these factors at microdose level is limited, so treat them as points of attention rather than rules.

When to stop

Stop and talk to a doctor if you notice anxiety, low mood, sleep problems, palpitations or anything else that worries you. Don't try to "push through" by taking more. Microdosing is not a substitute for medical care; the difference is explained in microdosing is not therapy.

In short

Microdosing sparks a lot of curiosity and plenty of personal stories. Research, however, calls for humility: effects are subtle when they exist, hard to distinguish from placebo, and different for everyone. If you're curious, go in with clear eyes, reasonable expectations and a microdosing journal to observe yourself honestly.

Important

• For adults only (18+).
• Not recommended during pregnancy or breastfeeding, if you have a personal or family history of psychotic or bipolar disorders, if you have a heart condition, or if you are taking medication (especially antidepressants or lithium).
• Do not drive or operate machinery after taking it. Do not combine with alcohol.
• Talk to a doctor before you start.
• Psilocybin truffles are sold legally in the Netherlands, where BIEN is based. Their status varies from country to country: check the legislation in your country.

FAQ

What does microdosing do?

Research has not established what microdosing does beyond placebo. People describe a range of subjective experiences, from feeling a little more present to noticing nothing at all, and some report unpleasant effects.

What are the side effects of microdosing?

People report restlessness, nervousness, headaches, an upset stomach, trouble sleeping or tiredness the next day. Reports vary, and long-term data are missing. If something doesn't feel right, stop and talk to a doctor.

Is microdosing just a placebo?

The best available studies suggest that expectations explain a large part of what people report. That doesn't prove there is no effect at all, but no reliable effect beyond placebo has been demonstrated so far.

Why do I feel nothing when I microdose?

That is a common experience, and it fits the aim of staying below the threshold of noticeable effects. Taking more to feel something is not recommended.

Sources

• Szigeti B. et al. (2021), Self-blinding citizen science to explore psychedelic microdosing, eLife.
• European Union Drugs Agency (EUDA): information on drugs in Europe.
• PubMed: studies on microdosing, database of the U.S. National Library of Medicine.